Rosemary E. Gale

14.2k total citations · 3 hit papers
115 papers, 7.4k citations indexed

About

Rosemary E. Gale is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Rosemary E. Gale has authored 115 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 41 papers in Genetics and 36 papers in Molecular Biology. Recurrent topics in Rosemary E. Gale's work include Acute Myeloid Leukemia Research (58 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers) and Acute Lymphoblastic Leukemia research (26 papers). Rosemary E. Gale is often cited by papers focused on Acute Myeloid Leukemia Research (58 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers) and Acute Lymphoblastic Leukemia research (26 papers). Rosemary E. Gale collaborates with scholars based in United Kingdom, United States and France. Rosemary E. Gale's co-authors include David C. Linch, Alan K. Burnett, Robert K. Hills, Panagiotis Kottaridis, Keith Wheatley, Stephen E. Langabeer, David Bowen, Marion E. Frew, Asim Khwaja and Christopher Allen and has published in prestigious journals such as Nature, The Lancet and Nature Genetics.

In The Last Decade

Rosemary E. Gale

115 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

2001 1.2k citations Panagiotis Kottaridis, Rosemary E. Gale et al. Blood profile →
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

2007 522 citations Rosemary E. Gale, Claire Green et al. Blood profile →
Acute myeloid leukaemia

2016 289 citations Asim Khwaja, Rosemary E. Gale et al. profile →

Peers

Countries citing papers authored by Rosemary E. Gale

Since Specialization

Citations

This map shows the geographic impact of Rosemary E. Gale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary E. Gale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary E. Gale more than expected).

Fields of papers citing papers by Rosemary E. Gale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary E. Gale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary E. Gale. The network helps show where Rosemary E. Gale may publish in the future.

Co-authorship network of co-authors of Rosemary E. Gale

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary E. Gale. A scholar is included among the top collaborators of Rosemary E. Gale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary E. Gale. Rosemary E. Gale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapy for isocitrate dehydrogenase 2 (IDH2)^R172‐mutant acute myeloid leukaemia 2021 ·British Journal of Haematology ·David C. Linch, Robert K. Hills, Alan K. Burnett, Nigel H. Russell, Rosemary E. Gale	2
2	Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols 2021 ·Leukemia ·Mary Taj, Anthony V. Moorman, (unknown), Arnaud Petit, Vahid Asnafi, Fanny Alby‐Laurent, Ajay Vora, Marc R. Mansour, Rosemary E. Gale, Sylvie Chevret, John Moppett, André Baruchel, Elizabeth Macintyre	4
3	Frequency of NPM1 Mutations in Pakistani Acute Myeloid Leukemia Patients 2013 ·Pakistan Journal of Zoology ·Akbar Ali, (unknown), Rosemary E. Gale, Abdul Rauf Shakoori	4
4	The replication rate of human hematopoietic stem cells in vivo 2011 ·Blood ·Sandra N. Catlin, Lambert Busque, Rosemary E. Gale, Peter Guttorp, Janis L. Abkowitz	159
5	In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm 2009 ·Blood ·Jonathan Lambert, Tamara Everington, David C. Linch, Rosemary E. Gale	29
6	Most acute myeloid leukaemia patients with intermediate mutant FLT3/ITD levels do not have detectable bi‐allelic disease, indicating that heterozygous disease alone is associated with an adverse outcome 2008 ·British Journal of Haematology ·Claire Green, David C. Linch, Rosemary E. Gale	6
7	Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia 2008 ·Genes Chromosomes and Cancer ·Manu Gupta, Manoj Raghavan, Rosemary E. Gale, Claude Chelala, Christopher Allen, Gael Molloy, Tracy Chaplin, David C. Linch, Jean‐Baptiste Cazier, Bryan D. Young	66
8	The expression of prion protein (PrPC) in the megakaryocyte lineage 2005 ·Journal of Thrombosis and Haemostasis ·Richard Starke, Paul Harrison, Ian Mackie, Gong Wang, Jorge D. Erusalimsky, Rosemary E. Gale, JM Masse, Elisabeth M. Cramer, Arnold Pizzey, John Biggerstaff, SJ Machin	24
9	Flt3 mutations and leukaemia 2003 ·British Journal of Haematology ·Panagiotis Kottaridis, Rosemary E. Gale, David C. Linch	112
10	An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia 2002 ·Oncogene ·Louisa V. Forbes, Rosemary E. Gale, Arnold Pizzey, K Pouwels, Amit Nathwani, David C. Linch	51
11	Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia 2002 ·Blood ·Phil Ancliff, Rosemary E. Gale, Michael Watts, Ri Liesner, Ian Hann, Stephan Ströbel, David C. Linch	57
12	Lack of pathogenic mutations in the 5′‐untranslated region of the thrombopoietin gene in patients with non‐familial essential thrombocythaemia 2001 ·European Journal Of Haematology ·(unknown), Rosemary E. Gale, Claire Harrison, Samuel J. Machin, David C. Linch	10
13	Activating point mutations in the β_C chain of the GM‐CSF, IL‐3 and IL‐5 receptors are not a major contributory factor in the pathogenesis of acute myeloid leukaemia 1998 ·British Journal of Haematology ·Robin Freeburn, Rosemary E. Gale, David C. Linch	8
14	A Truncated Isoform of the Human β Chain Common to the Receptors for Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-3 (IL-3), and IL-5 With Increased mRNA Expression in Some Patients With Acute Leukemia 1998 ·Blood ·Rosemary E. Gale, Robin Freeburn, Asim Khwaja, Rajesh Chopra, David C. Linch	3
15	Acquired skewing of X‐chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age 1997 ·British Journal of Haematology ·Rosemary E. Gale, Adele K. Fielding, Claire Harrison, David C. Linch	190
16	Amplification of mitochondrial DNA in acute myeloid leukaemia 1996 ·British Journal of Haematology ·Jacqueline Boultwood, Carrie Fidler, Ken Mills, (unknown), Rajko Kušec, Alexander Gaiger, Rosemary E. Gale, D C Linch, Timothy J. Littlewood, Paul Moss, J. S. Wainscoat	54
17	Analysis of granulocyte colony stimulating factor receptor isoforms, polymorphisms and mutations in normal haemopoietic cells and acute myeloid leukaemia blasts 1996 ·British Journal of Haematology ·(unknown), Rosemary E. Gale, David C. Linch	36
18	Yersinia enterocolitica transmission from a red cell unit 34 days old 1996 ·Transfusion Medicine ·Carl McDonald, J. A. J. Barbara, Patricia E. Hewitt, Stephen W. Hartley, Paul Telfer, Rosemary E. Gale, (unknown), H. G. Prentice	16
19	Facilitated uptake of zinc into human erythrocytes 1990 ·Biochemical Pharmacology ·Robert C. Hider, Linda Ejim, Paul D. Taylor, Rosemary E. Gale, E. R. Huehns, John B. Porter	33
20	Haemoglobin Radcliffe (α₂β₂^99(G1)Ala): A High Oxygen‐Affinity Variant Causing Familial Polycythaemia 1977 ·British Journal of Haematology ·D. J. Weatherall, J. B. Clegg, Sheila T. Callender, R.M.G. Wells, Rosemary E. Gale, E. R. Huehns, M. F. Perutz, (unknown), Chien Ho	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact